Takeda Lowers 2025 Outlook After Weak Q2 And Pipeline Impairment Charges

benzinga.com/markets/earnings/25/10/48526401/takeda-lowers-2025-outlook-after-weak-q2-and-pipeline-impairment-charges

Takeda Pharmaceutical Company Limited (NYSE:TAK) posted a second-quarter 2025 adjusted net profit of 201.6 billion Japanese yen (approximately $1.31 billion).
The company reported earnings per American Depositary Share (EPADS) of 43 cents, missing analyst expectations of 44 cents.…

This story appeared on benzinga.com, 2025-10-30 13:13:01.
The Entire Business World on a Single Page. Free to Use →